QbD: Time to Market
- December 2011
- Pharmaceutical Manufacturing
Are you factoring in the potential cost of unexpected failure?
Published Articles
Tunnell’s subject matter experts have written a number of informative pieces. Here are a sampling of articles that have been published in leading industry publications.
Impact of cGMP on Supply Chain
- July 2011
- BioPharm International
Incorporating regulatory requirements into the product life-cycle plan is crucial for supply chain security and patient safety.
QbD: The Case for Change (Part 2)
- March 2011
- BioPharm International
A rigorous cost benefit assessment can help to chart a cost-effective path forward.
Supply Chain Transformation: Strategic Necessity for the Life Sciences
- March 2011
- BioPharm International
New supply chain challenges, including counterfeits, are forcing companies to act in different ways to secure produce safety.
QbD: The Case for Change
- March 2011
- BioPharm International
Executive management leadership is essential in the effective implementation of QbD.
Keys to a Successful Technology Transfer
- February 2011
- Pharmaceutical Technology
Poor planning and misguided implementation when conducting technology transfer can lead to problems with budget, scheduling, compliance and supply.